Discovery of an unexpected protein-protein interaction has led scientists to identify a drug that slows the progression of amyotrophic lateral sclerosis in mice and nearly doubles the animals’ lifespan. ALS, also known as Lou Gehrig’s disease, is a fatal, progressive neurodegenerative disease that affects the motor nerve cells of the brain and spinal cord.